home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

A New Progenitor Cell Population in Breast Cancer

  August, 13 2009 15:12
your information resource in human molecular genetics

Some breast cancers are thought to arise from mammary stem cells that mutate, but a study published in Nature Medicine indicates that luminal cells that line the mammary ducts may also be tumor progenitors.

Basal-like breast cancers arise in women carrying mutations in the gene encoding the tumor suppressor protein BRCA1. Jane Visvader and her colleagues isolated distinct cell populations from normal mammary tissue and pre-cancerous tissue from women who have one normal BRCA1 gene and one BRCA1 gene mutation. They found that breast tissue from BRCA1 mutation women harbors an expanded luminal progenitor population. Analysis of gene expression patterns showed that basal breast cancer tumor cells were more similar to the luminal progenitor cells than to any other cell type, including the stem cell population.

The discovery of an aberrant luminal progenitor population in pre-cancerous tissue from BRCA1 mutation carriers establishes these cells as a probable target population in the fight against such breast tumors.

Author Contact:

Jane Visvader (The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia)
E-mail: visvader@wehi.edu.au

Abstract available online.

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.